Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features. Issue 5 (25th January 2023)

• Record Type: Journal Article
• Authors: Haefliger, Simon; Hench, Juergen; O'Rourke, Colm J; Meyer‐Schaller, Nathalie; Uzun, Sarp; Saldarriaga, Joan; Weber, Achim; Mazzucchelli, Luca; Jermann, Philip; Frank, Stephan; Andersen, Jesper B; Terracciano, Luigi; Sempoux, Christine; Matter, Matthias S
• Is Part Of: Histopathology. Volume 82:Issue 5(2023)
• Page Start: 722
• Page End: 730
• Publication Date: 2023-01-25
• Subjects: epigenetic -- hepatocellular adenoma -- hepatocellular carcinoma -- liver -- methylation analysis -- next generation sequencing; Histology, Pathological -- Periodicals; 611.018
• DOI: 10.1111/his.14858
• Languages: English
• ISSNs: 0309-0167

Abstract

Abstract : Background: Hepatocellular adenoma (HCA) is a rare liver tumour, which can have atypical morphological features such as cytological atypia, pseudoglandular architecture, and altered reticulin framework. Little is known about the genetic and epigenetic alterations of such HCAs and whether they show the alterations classically found in hepatocellular carcinoma (HCC) or in HCA without atypical morphology. Methods: We analysed five HCAs with atypical morphological features and one HCA with transition to HCC. Every tumour was subtyped by immunohistochemistry, sequenced by a targeted NGS panel, and analysed on a DNA methylation microarray. Results: Subtyping of the five HCAs with atypical features revealed two β‐catenin mutated HCA (b‐HCA), two β‐catenin mutated inflammatory HCA (b‐IHCA), and one sonic hedgehog activated HCA (shHCA). None of them showed mutations typically found in HCC, such as, e.g. TERT or TP53 mutations. The epigenomic pattern of HCAs with atypical morphological features clustered with reference data for HCAs without atypical morphological features but not with HCC. Similarly, phyloepigenetic trees using the DNA methylation data reproducibly showed that HCAs with morphological atypia are much more similar to nonmalignant samples than to malignant samples. Finally, atypical HCAs showed no relevant copy number variations (CNV). Conclusion: In our series, mutational, DNA methylation, as well as CNV analyses, supported a relationship of atypical HCAs with nonatypical HCAs rather than with HCC. Therefore, in cases with difficult differential diagnosis between HCC and HCA, it might be advisable to perform targeted sequencing and/or combined methylation/copy number profiling. Abstract : In liver tumours with difficult differential diagnosis between HCA with morphological atypia and HCC, molecular analyses supported a relationship with nonatypical HCAs and not with HCC.